patient rights continues to be a major concern of ours and I would echo a lot of the issues that we raised back in March. DOCTOR SLOANE: Can you go back to what you just said again? I missed the most recent comment you just made. MR. ERWIN: On informed consent? DOCTOR SLOANE: Yes. MR. ERWIN: So the informed consent piece is also mirrored in 2.43, 3.0 which we heard back in so our comments pretty much reflect what was said back then. There currently are requirements and guidance on best practices including CMS standards, ACS standards and the Board's current regulations, which we believe are clear and highly effective, ensuring that patients are provided all relevant information prior to deciding on a clinical course. the concerns we have is that the application of this provision is to, quote, any diagnostic, therapeutic or invasive procedure, medical intervention or treatment, which pretty much mean every patient encounter. The proposal also requires information that may not be known at
patient rights continues to be a major concern of ours and I would echo a lot of the issues that we raised back in March. DOCTOR SLOANE: Can you go back to what you just said again? I missed the most recent comment you just made. MR. ERWIN: On informed consent? DOCTOR SLOANE: Yes. MR. ERWIN: So the informed consent piece is also mirrored in 2.43, 3.0 which we heard back in so our comments pretty much reflect what was said back then. There currently are requirements and guidance on best practices including CMS standards, ACS standards and the Board's current regulations, which we believe are clear and highly effective, ensuring that patients are provided all relevant information prior to deciding on a clinical course. the concerns we have is that the application of this provision is to, quote, any diagnostic, therapeutic or invasive procedure, medical intervention or treatment, which pretty much mean every patient encounter. The proposal also requires information that may not be known at
transcript-234CMR2.docx